E2F3 and fetal growth restriction: Immunohistochemistry revealed E2F3 expressed in alveolar regions (Fig 5), with a significant increase in E2F3 level in the alveoli surface from P10 to P21 in control samples, but no significant difference in level between LPD-induced IUGR and control lungs.